M. Bhandari Chem. Profile
Key Indicators
- Authorised Capital ₹ 0.75 M
as on 03-01-2025
- Paid Up Capital ₹ 0.41 M
as on 03-01-2025
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -30.64%
(FY 2020)
- Profit -90.18%
(FY 2020)
- Ebitda -28.00%
(FY 2020)
- Net Worth 3.46%
(FY 2020)
- Total Assets 27.34%
(FY 2020)
About M. Bhandari Chem.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.75 M and a paid-up capital of Rs 0.41 M, as per Ministry of Corporate Affairs (MCA) records.
Neeru Bhandari and Prakash Babulal serve as directors at the Company.
- CIN/LLPIN
U24100GJ2009PTC057018
- Company No.
057018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2009
- Date of AGM
10 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does M. Bhandari Chem. Private Limited offer?
M. Bhandari Chem. Private Limited offers a wide range of products and services, including Dairy Products, Dairy Chemical Products, Testing & Measuring Equipments, Food Testing Equipment.
Who are the key members and board of directors at M. Bhandari Chem.?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeru Bhandari  | Director | 21-May-2009 | Current |
| Prakash Babulal | Director | 21-May-2009 | Current |
Financial Performance of M. Bhandari Chem..
M. Bhandari Chem. Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 30.64% decrease. The company also saw a substantial fall in profitability, with a 90.18% decrease in profit. The company's net worth moved up by a moderate rise of 3.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M. Bhandari Chem.?
In 2018, M. Bhandari Chem. had a promoter holding of 90.12% and a public holding of 9.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr. Respira Care Private LimitedActive 2 years 8 monthsNeeru Bhandari and Prakash Babulal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at M. Bhandari Chem.?
Unlock and access historical data on people associated with M. Bhandari Chem., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M. Bhandari Chem., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M. Bhandari Chem.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
